53BP1 oligomerization is independent of its methylation by PRMT1

被引:64
作者
Adams, MM
Wang, B
Xia, ZF
Morales, JC
Lu, XB
Donehower, LA
Bochar, DA
Elledge, SJ
Carpenter, PB
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA
[3] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[4] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
arginine methylation; tumor suppressor; cell cycle; oligomerization; DNA repair;
D O I
10.4161/cc.4.12.2282
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p53 binding protein 1 (53BP1) participates in the repair of DNA double stranded breaks (DSBs) where it is recruited to or near sites of DNA damage. Although little is known about the biochemical functions of 53BP1, the protein possesses several motifs that are likely important for its role as a DNA damage response element. This includes two BRCA1 C-terminal repeats, tandem Tudor domains, and a variety of phosphorylation sites. Here we show that a glycine-arginine rich (GAR) stretch of 53BP1 lying upstream of the Tudor motifs is methylated. We demonstrate that arginine residues within this region are important for asymmetric methylation by the PRMT1 methyltransferase. We further show that sequences upstream of the Tudor domains that do not include the GAR stretch are sufficient for 53BP1 oligomerization in vivo. Thus, although Tudor domains bind methylated proteins, 53BP1 homo-oligomerization occurs independently of Tudor function. Lastly, we find that deficiencies in 53BP1 generate a "hyper-rec" phenotype. Collectively, these data provide new insight into 53BP1, an important component in maintaining genomic stability.
引用
收藏
页码:1854 / 1861
页数:8
相关论文
共 32 条
  • [1] Cell cycle checkpoint signaling through the ATM and ATR kinases
    Abraham, RT
    [J]. GENES & DEVELOPMENT, 2001, 15 (17) : 2177 - 2196
  • [2] Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1
    Bekker-Jensen, S
    Lukas, C
    Melander, F
    Bartek, J
    Lukas, J
    [J]. JOURNAL OF CELL BIOLOGY, 2005, 170 (02) : 201 - 211
  • [3] Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control
    Boisvert, FM
    Déry, U
    Masson, JY
    Richard, S
    [J]. GENES & DEVELOPMENT, 2005, 19 (06) : 671 - 676
  • [4] A proteomic analysis of arginine-methylated protein complexes
    Boisvert, FM
    Côté, J
    Boulanger, MC
    Richard, S
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (12) : 1319 - 1330
  • [5] The tudor tandem of 53BP1:: A new structural motif involved in DNA and RG-rich peptide binding
    Charier, G
    Couprie, J
    Alpha-Bazin, B
    Meyer, V
    Quéméneur, E
    Guérois, R
    Callebaut, I
    Gilquin, B
    Zinn-Justin, S
    [J]. STRUCTURE, 2004, 12 (09) : 1551 - 1562
  • [6] Cote J., 1995, METHODS MOL GENETICS, V6, P108
  • [7] 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer
    DiTullio, RA
    Mochan, TA
    Venere, M
    Bartkova, J
    Sehested, M
    Bartek, J
    Halazonetis, TD
    [J]. NATURE CELL BIOLOGY, 2002, 4 (12) : 998 - 1002
  • [8] DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1
    Fernandez-Capetillo, O
    Chen, HT
    Celeste, A
    Ward, I
    Romanienko, PJ
    Morales, JC
    Naka, K
    Xia, ZF
    Camerini-Otero, RD
    Motoyama, N
    Carpenter, PB
    Bonner, WM
    Chen, JJ
    Nussenzweig, A
    [J]. NATURE CELL BIOLOGY, 2002, 4 (12) : 993 - 997
  • [9] The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity
    Frankel, A
    Yadav, N
    Lee, JH
    Branscombe, TL
    Clarke, S
    Bedford, MT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) : 3537 - 3543
  • [10] p53-binding protein 1 is fused to the platelet-derived growth factor receptor β in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder
    Grand, FH
    Burgstaller, S
    Kühr, T
    Baxter, EJ
    Webersinke, G
    Thaler, J
    Chase, AJ
    Cross, NCP
    [J]. CANCER RESEARCH, 2004, 64 (20) : 7216 - 7219